ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 138 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $125 | -18.3% | 18,684 | +2.7% | 0.00% | – |
| Q2 2023 | $153 | -84.7% | 18,200 | +4818.9% | 0.00% | – |
| Q2 2022 | $1,000 | -99.3% | 370 | -98.9% | 0.00% | – |
| Q1 2022 | $143,000 | +10.9% | 32,203 | 0.0% | 0.00% | – |
| Q4 2021 | $129,000 | -54.6% | 32,203 | -0.4% | 0.00% | – |
| Q3 2021 | $284,000 | -39.6% | 32,332 | -22.1% | 0.00% | – |
| Q2 2021 | $470,000 | +993.0% | 41,500 | +135.8% | 0.00% | – |
| Q1 2020 | $43,000 | -57.8% | 17,600 | 0.0% | 0.00% | – |
| Q4 2019 | $102,000 | +9.7% | 17,600 | 0.0% | 0.00% | – |
| Q3 2019 | $93,000 | -12.3% | 17,600 | 0.0% | 0.00% | – |
| Q2 2019 | $106,000 | -33.3% | 17,600 | 0.0% | 0.00% | – |
| Q1 2019 | $159,000 | +8.9% | 17,600 | 0.0% | 0.00% | – |
| Q4 2018 | $146,000 | -39.9% | 17,600 | 0.0% | 0.00% | – |
| Q3 2018 | $243,000 | +73.6% | 17,600 | 0.0% | 0.00% | – |
| Q2 2018 | $140,000 | – | 17,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,031,915 | $20,253,192 | 21.02% |
| Perceptive Advisors | 11,350,085 | $75,818,568 | 2.53% |
| JOHNSON & JOHNSON | 394,834 | $2,637,491 | 0.97% |
| Joseph P. Lucia & Associates, LLC | 28,331 | $189,251 | 0.13% |
| WOODSTOCK CORP | 137,179 | $916,356 | 0.12% |
| Palo Alto Investors LP | 160,800 | $1,074,144 | 0.10% |
| Affinity Asset Advisors, LLC | 44,348 | $296,245 | 0.08% |
| Verition Fund Management LLC | 935,273 | $6,247,624 | 0.07% |
| FOX RUN MANAGEMENT, L.L.C. | 33,519 | $223,907 | 0.07% |
| TOBIAS FINANCIAL ADVISORS, INC. | 34,173 | $228,276 | 0.06% |